Menu

BSE

MRF Shares Soar Above ₹1.5 Lakh, Reaching a 52-Week Peak!

The Stocks Of Indian Infotech Stock Soar After Receiving Board’s Nod For 47 Cr Rights Issue

The Stocks Of Indian Infotech Stock Soar After Receiving Board’s Nod For 47 Cr Rights Issue

A closer look at the recent surge in Indian Infotech and Software Ltd’s stock following a major capital-raising move, and what it means for investors.

Introduction
Penny stocks often fly under the radar, but when a company in this segment announces a major capital-raising initiative, the market takes notice. Indian Infotech and Software Ltd (BSE: 509051), a micro-cap IT services provider, has recently made headlines with its Board’s decision to launch a rights issue totaling Rs 47 crore. This move, coupled with recent changes in the company’s boardroom, has set the stage for a new chapter in its corporate journey.

The Rights Issue: Details and Implications
Indian Infotech’s Rs 47 Crore Rights Issue
On June 23, 2025, the Board of Indian Infotech and Software Ltd approved a rights offering of fully paid equity shares, with the aggregate issue size limited to Rs 47 Cr. The record date for eligibility will be announced soon, and the issue will be conducted in accordance with SEBI’s capital and disclosure regulations.
Why Now?
The company’s decision comes at a time when it seeks to bolster its working capital and fund general corporate purposes. Raising fresh equity through a rights issue is a strategic move, especially for a company with a modest market capitalization and a volatile stock price history.

Recent Corporate Developments
Boardroom Changes
Coinciding with the rights issue announcement, Indian Infotech and Software Ltd accepted the resignation of Independent Director Ms. Aksha Bihani, effective June 16, 2025. Such changes often signal a period of transition and renewed strategic focus for the company2.
Board Meeting Timeline
The decision to pursue a rights issue was preceded by a series of Board meetings in June 2025, where directors deliberated on the company’s capital requirements and fundraising options. The move from discussing general fundraising to specifically approving a rights issue underscores the urgency and importance of this capital infusion.

Stock Performance: Multibagger Moves and Volatility
Price Action
Though considered a penny stock, Indian Infotech and Software Ltd has undergone several periods of significant price fluctuations. As of June 11, 2025, the stock was trading at Rs 1.03, with a 52-week range between Rs 0.73 and Rs 1.78. The announcement of the rights issue has led to a surge in trading volumes, reflecting heightened investor interest.
Returns Snapshot
• 1-Month Return: +1.98%
• 3-Month Return: -13.45%
• 1-Year Return: -26.43%
• 5-Year Return: +442.11%
While recent returns have been negative, the long-term chart reveals multibagger potential for those who entered at historical lows.

Market Sentiment and Investor Outlook
Why Are Investors Interested?
Rights issues in penny stocks often attract speculative interest, given the potential for sharp moves if the company successfully deploys the new capital. For Indian Infotech and Software Ltd, the rights issue is seen as a vote of confidence by management in the company’s future prospects.
Risks and Rewards
Investors should note that while the rights issue offers an opportunity to buy additional shares, the underlying business fundamentals and execution of growth plans remain critical. Penny stocks carry a high level of risk due to their extreme price fluctuations and low trading volumes, making thorough research and caution crucial before investing.

What’s Next for Indian Infotech and Software Ltd?
Key Dates to Watch
• Announcement of the record date for rights issue eligibility.
• Disclosure of issue price and ratio.
• Updates on the utilization of funds post-issue.
Strategic Focus
The capital raised will likely be directed toward strengthening the company’s balance sheet and supporting business expansion. The success of the rights issue and subsequent deployment of funds will be crucial in determining the company’s trajectory in the coming quarters.

Conclusion
This move has revitalized investor sentiment, drawing increased interest from both retail and institutional participants. While the company’s multibagger history and recent developments are promising, prudent investors should keep an eye on the execution of its capital plans and evolving corporate governance.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Nestlé India Removed from Sensex: Signaling India’s Changing Economic Landscape

MRF Shares Soar Above ₹1.5 Lakh, Reaching a 52-Week Peak!

The Stocks Of Indian Infotech Stock Soar After Receiving Board’s Nod For 47 Cr Rights Issue

The Stocks Of Indian Infotech Stock Soar After Receiving Board’s Nod For 47 Cr Rights Issue

A closer look at the recent surge in Indian Infotech and Software Ltd’s stock following a major capital-raising move, and what it means for investors.

Introduction
Penny stocks often fly under the radar, but when a company in this segment announces a major capital-raising initiative, the market takes notice. Indian Infotech and Software Ltd (BSE: 509051), a micro-cap IT services provider, has recently made headlines with its Board’s decision to launch a rights issue totaling Rs 47 crore. This move, coupled with recent changes in the company’s boardroom, has set the stage for a new chapter in its corporate journey.

The Rights Issue: Details and Implications
Indian Infotech’s Rs 47 Crore Rights Issue
On June 23, 2025, the Board of Indian Infotech and Software Ltd approved a rights offering of fully paid equity shares, with the aggregate issue size limited to Rs 47 Cr. The record date for eligibility will be announced soon, and the issue will be conducted in accordance with SEBI’s capital and disclosure regulations.
Why Now?
The company’s decision comes at a time when it seeks to bolster its working capital and fund general corporate purposes. Raising fresh equity through a rights issue is a strategic move, especially for a company with a modest market capitalization and a volatile stock price history.

Recent Corporate Developments
Boardroom Changes
Coinciding with the rights issue announcement, Indian Infotech and Software Ltd accepted the resignation of Independent Director Ms. Aksha Bihani, effective June 16, 2025. Such changes often signal a period of transition and renewed strategic focus for the company2.
Board Meeting Timeline
The decision to pursue a rights issue was preceded by a series of Board meetings in June 2025, where directors deliberated on the company’s capital requirements and fundraising options. The move from discussing general fundraising to specifically approving a rights issue underscores the urgency and importance of this capital infusion.

Stock Performance: Multibagger Moves and Volatility
Price Action
Though considered a penny stock, Indian Infotech and Software Ltd has undergone several periods of significant price fluctuations. As of June 11, 2025, the stock was trading at Rs 1.03, with a 52-week range between Rs 0.73 and Rs 1.78. The announcement of the rights issue has led to a surge in trading volumes, reflecting heightened investor interest.
Returns Snapshot
• 1-Month Return: +1.98%
• 3-Month Return: -13.45%
• 1-Year Return: -26.43%
• 5-Year Return: +442.11%
While recent returns have been negative, the long-term chart reveals multibagger potential for those who entered at historical lows.

Market Sentiment and Investor Outlook
Why Are Investors Interested?
Rights issues in penny stocks often attract speculative interest, given the potential for sharp moves if the company successfully deploys the new capital. For Indian Infotech and Software Ltd, the rights issue is seen as a vote of confidence by management in the company’s future prospects.
Risks and Rewards
Investors should note that while the rights issue offers an opportunity to buy additional shares, the underlying business fundamentals and execution of growth plans remain critical. Penny stocks carry a high level of risk due to their extreme price fluctuations and low trading volumes, making thorough research and caution crucial before investing.

What’s Next for Indian Infotech and Software Ltd?
Key Dates to Watch
• Announcement of the record date for rights issue eligibility.
• Disclosure of issue price and ratio.
• Updates on the utilization of funds post-issue.
Strategic Focus
The capital raised will likely be directed toward strengthening the company’s balance sheet and supporting business expansion. The success of the rights issue and subsequent deployment of funds will be crucial in determining the company’s trajectory in the coming quarters.

Conclusion
This move has revitalized investor sentiment, drawing increased interest from both retail and institutional participants. While the company’s multibagger history and recent developments are promising, prudent investors should keep an eye on the execution of its capital plans and evolving corporate governance.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Nestlé India Removed from Sensex: Signaling India’s Changing Economic Landscape

Tata Elxsi Q1 FY26 Net Profit Drops 22% Amid Global Headwinds

BSE Shares Decline as Inclusion in ASM Framework Triggers Market Caution

BSE Shares Decline as Inclusion in ASM Framework Triggers Market Caution

Shares of BSE Ltd. witnessed a sharp decline after being added to the Additional Surveillance Measure (ASM) list, raising immediate caution among traders and investors. The stock dropped by nearly 4% on June 11, with the downward trend continuing into the following trading session. Over two consecutive days, BSE’s shares tumbled more than 7%, as market participants reacted quickly to the regulatory update, adjusting their strategies amid concerns over tighter trading norms.

What is the ASM Framework?

The Additional Surveillance Measure (ASM) framework, introduced by SEBI and the stock exchanges, is designed to monitor stocks that display extraordinary price volatility or significant increases in trading volumes. When a stock is placed under ASM, it does not suggest any misconduct or problem within the company. Instead, the purpose is to protect market stability by discouraging speculative trading through tighter margin requirements, restricted intraday trading, and increased regulatory supervision.

Why BSE Shares Came Under Scrutiny

BSE Ltd. attracted regulatory attention due to its exceptional price rally over the past several months. The company’s stock surged over 120% in the last three months, recorded an impressive 225% gain over the previous year, and appreciated by nearly 32% in just one month. Importantly, this steep rise occurred without any significant company announcements or business developments. Such rapid and unexplained price movements are typically flagged by regulators, leading to the stock’s inclusion in the ASM list to ensure that excessive speculation does not destabilize the market.

How the Market Reacted

After being placed under the ASM category, BSE shares faced significant selling activity. On June 11, the stock slipped to an intraday low of ₹2,885.20, marking a close to 4% decline in a single day. The selling pressure persisted on June 12, pushing the stock down further to nearly ₹2,786.80. Within just two trading sessions, BSE’s market value eroded by over 7%, underlining the immediate impact that regulatory monitoring can have on stock performance.

Technical View and Financial Strength

From a technical standpoint, despite this recent fall, the stock is still trading above long-term support levels such as the 50-day and 200-day Simple Moving Averages (SMA). However, the stock has dipped below its 5-day SMA, which signals short-term weakness. Previously, the Relative Strength Index (RSI) indicated overbought conditions, suggesting that the stock was likely due for a correction.

Looking at the financial performance, BSE Ltd. continues to deliver strong results. During the fourth quarter of FY25, the company posted an impressive net profit of ₹494 crore, reflecting a substantial 362% growth compared to the same period last year. Its revenue also witnessed a sharp rise of 75%, reaching ₹847 crore, while EBITDA margins expanded to 70%, underscoring improved operational effectiveness. Additionally, transaction fee income more than doubled to ₹612 crore, underscoring the resilience of BSE’s core business operations.

What This Means for Investors

Stocks listed under the ASM framework often witness short-lived price fluctuations since the increased margin demands and restricted trading conditions generally limit speculative activity. However, this should not be misinterpreted as a negative reflection on the company’s long-term fundamentals. For long-term investors, this phase could present an opportunity to reassess the stock’s valuation and growth prospects. Meanwhile, short-term traders should remain cautious, as the new trading restrictions could increase costs and impact daily trading strategies.

The Bigger Picture: Role of the ASM Framework

The ASM framework plays a vital role in maintaining the integrity of financial markets by closely tracking stocks with sudden and aggressive price actions. A stock may be removed from the ASM framework if its price movements and trading activity return to more stable and consistent patterns. Companies like BSE, which are financially sound, often regain investor trust once the additional regulatory oversight is lifted.

What to Watch Going Ahead

Several factors may influence the future price movement of BSE shares:

Global and Domestic Market Sentiment: Overall trends in Indian and global equity markets will continue to impact stock prices.

Trading Volumes: A gradual reduction in abnormal trading volumes could help the stock move out of the ASM framework.

Institutional Investment Activity: Buying or selling actions by large domestic and foreign investors will remain important indicators.

Regulatory Developments: Future updates regarding BSE’s status under ASM monitoring will be crucial for investors to track.

Conclusion

The recent drop in BSE Ltd’s stock price following its addition to the ASM framework has led to a wave of caution among investors. While the regulatory move has temporarily impacted the stock’s momentum, the company’s strong financial growth, expanding margins, and steady revenue performance demonstrate that its long-term business outlook remains healthy. Investors should focus on the company’s fundamentals and watch for regulatory and market updates as the stock adjusts to the new trading environment.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

India Set to Invest $600 Million in Crude Tankers

BSE Prices Double: Derivatives Surge and IPO Buzz

BSE Prices Double: Derivatives Surge and IPO Buzz!

BSE Prices Double: Derivatives Surge and IPO Buzz

BSE Ltd. rallies over 91% in just two months, driven by booming F&O market share, robust Q4 and FY25 earnings, and increased investor optimism around Sebi reforms and the upcoming NSE IPO.

Summary:

BSE Ltd. experienced a 91% increase in its stock price between March 11 and May 16, 2025, coming close to doubling its value. This significant rise is due to a growing share in the Futures and Options (F&O) segment, robust profit performance for fiscal year 2025, and heightened investor interest driven by anticipated news regarding the National Stock Exchange’s IPO. Regulatory changes by Sebi and a shift in market volumes from NSE to BSE have further cemented the stock’s bullish momentum.

BSE Stock Soars 91%: What’s Driving the Rally?

In one of the most talked-about stock rallies of 2025, BSE Ltd. (Bombay Stock Exchange) has more than doubled its share price from its March 11 lows, surging a spectacular 91% by May 16. This meteoric rise is not a mere speculative swing—it’s fueled by a confluence of fundamental tailwinds, regulatory shifts, and changing market dynamics in India’s capital markets.
The company, historically known for its equity cash segment, is now seeing unprecedented traction in the derivatives (F&O) market, with growing volumes and market share that threaten NSE’s long-standing dominance. This increase in activity and strong earnings growth in FY25 changes how investors view and value the exchange.

Key Drivers of BSE’s Price Rally

1. Rising Market Share in F&O Segment
One of the primary catalysts behind the price explosion is BSE’s aggressive expansion in the equity derivatives segment, particularly with its Sensex and Bankex contracts. BSE has successfully gained around 14–17% of the market share in F&O trading volumes—up from negligible levels just a year ago—thanks to:
Reduced transaction costs
Introduction of weekly expiry contracts
Increasing retail and algo trader participation
Regulatory reforms supporting competition between exchanges
This surge in derivatives trading has significantly boosted BSE’s transaction revenue and positioned it as a viable alternative to NSE’s once-unassailable grip on the F&O space.

2. Stellar FY25 Earnings Performance
BSE reported exceptional Q4 FY25 and full-year results, with:
Revenue growth of over 35% YoY,
Operating profit margin expansion of 600 bps,
Net profit increased significantly because of improved volumes and product diversification.
The exchange’s multi-year transformation strategy, including its foray into SME listings, commodity derivatives, and global IFSC markets, is finally bearing fruit. With new revenue streams and improved efficiency, investors are pricing higher future earnings potential, further justifying the stock’s re-rating.

3. Anticipation of NSE IPO
The long-delayed NSE IPO is gaining momentum after SEBI’s recent nod for regulatory clearance, sparking renewed interest in the broader exchange sector.
Investors are betting that NSE’s listing could:
Lead to sector-wide rerating of exchange valuations,
Improve transparency and governance benchmarks,
Prompt further innovation and pricing competition.
In this environment, BSE is seen as an early beneficiary, with its publicly listed status providing a valuation arbitrage for institutional investors seeking exposure to Indian capital market infrastructure.

4. Sebi’s Reforms Boosting Exchange Competition
SEBI has introduced a series of progressive reforms aimed at:
Leveling the playing field between exchanges,
Enhancing investor protection in the F&O segment,
Improving cost structures through reduced STT and regulatory levies.
These reforms have unlocked fresh interest in BSE, especially among retail and algorithmic traders, while enabling BSE to optimize its trading platform performance. The enhanced operational metrics have increased the exchange’s appeal to institutional and retail investors.

Valuation Rerating and Analyst Commentary

Following the stock’s surge, analysts have revised BSE’s target price upward, citing:
Improved earnings visibility from non-core businesses (such as insurance distribution and data services),
Significant operating leverage as volumes rise,
Strong cash position and dividend yield, offering downside protection.
Leading brokerages have changed their stance from ‘Neutral’ to ‘Buy,’ citing the stock’s undervalued nature compared to global peers and the headroom for further upside if F&O market share continues to rise.

Investor Sentiment and Trading Activity

Retail participation has surged sharply, with delivery volumes rising consistently and FII flows returning to the exchange-centric theme. BSE is also increasingly included in portfolio allocations by thematic funds focused on financial infrastructure, technology, and capital markets.
From March lows near ₹1,100 to recent highs around ₹2,100, the technical setup also shows strong momentum. The stock broke past resistance levels on heavy volumes and formed a bullish trend across moving averages.

Risks and Outlook

Despite the optimism, some analysts caution that:
The derivatives segment is highly competitive, and sustaining volumes will require continuous innovation.
Regulatory risks, including curbs on speculative trading, could affect growth.
A potential slowdown in retail trading activity due to macroeconomic uncertainties might impact short-term revenues.
However, BSE’s positioning favors the long-term structural shift in India’s capital markets, driven by tech-enabled trading, rising retail participation, and financial access democratization.

Conclusion

The near doubling of BSE’s share price in just two months underscores a paradigm shift in investor confidence in the company’s growth trajectory. With rising F&O dominance, robust earnings, favorable regulatory support, and the halo effect from the anticipated NSE IPO, BSE is no longer just a secondary exchange—it’s becoming a formidable force in India’s capital market ecosystem.
As institutional and retail flows continue to pour in, and with further product innovation in the pipeline, BSE’s stock may still have room to run. The exchange offers a compelling blend of growth, innovation, and market leadership for long-term investors in a transforming financial landscape.

 

 

 

The image added is for representation purposes only

On the Fast Track: Railway Stocks Steam Ahead Up to 14%

Raymond Realty to Make Its Debut on Stock Exchanges After Demerger in Q2

Raymond Realty Demerger Completed, Shareholders to Receive Shares on 1:1 Basis

Raymond Realty Demerger Completed, Shareholders to Receive Shares on 1:1 Basis

 

Raymond spins off its real estate arm, offering shareholders a 1:1 share allotment in the newly listed Raymond Realty Limited. Record date set for May 14, 2025, as the group sharpens its business focus.

Major Milestone: Demerger Becomes Effective

Earlier this year, the National Company Law Tribunal (NCLT) gave the green light to the long-awaited separation of Raymond’s real estate arm.
The demerger became operational on May 1, 2025, following the board’s resolution and regulatory filings. This marks a significant restructuring for Raymond, a brand synonymous with India’s lifestyle and textile sectors, as it continues to streamline its corporate structure for sharper business focus.

What the Demerger Means for Shareholders

According to the approved Scheme of Arrangement, shareholders of Raymond Limited (RL) will receive one share of Raymond Realty Limited (RRL) for each share they own in RL, based on a direct 1:1 exchange ratio.
There are no additional costs or actions required from shareholders. The record date to determine eligibility for this share allotment is Wednesday, May 14, 2025.
This implies that all investors owning Raymond shares at the end of that day will automatically receive an equivalent number of shares in the newly separated Raymond Realty.

Raymond Realty: A Standalone Growth Story

Raymond Realty, once a division within the parent company, is now a fully independent, listed entity. The move allows the real estate arm to pursue its own strategy, leadership, and capital allocation, much like recent demergers seen in other Indian conglomerates.
Raymond Realty has established a strong presence in Mumbai’s residential market, with luxury projects in Thane and joint development agreements in key city locations such as Bandra, Mahim, Sion, and Wadala. In the last financial year, the company reported revenues of ₹15.9 billion and an EBITDA of ₹3.7 billion, highlighting its operational strength and future potential.
The company’s aggressive expansion in the Mumbai Metropolitan Region, including six major joint development agreements, positions it as a significant player in India’s booming real estate sector.

Strategic Rationale: Focus, Agility, and Value Creation

This demerger is part of a broader trend among Indian corporates to unlock value by spinning off high-growth verticals into standalone companies. Through the separation of its real estate division, Raymond intends to:
• Enhance operational focus for both businesses
• Enable agile, sector-specific decision-making
• Attract targeted investment and strategic partnerships
• Maximize long-term shareholder value
The move follows Raymond’s earlier spin-off of its lifestyle and fashion business, which was also listed as a separate entity. The group’s restructuring strategy reflects a clear intent to sharpen its business focus and respond to evolving market opportunities.

What’s Next for Investors?

Shareholders should ensure their holdings are updated and dematerialized before the record date of May 14, 2025, to be eligible for the 1:1 share allotment in Raymond Realty. After the listing, investors will be able to trade Raymond Realty shares independently of Raymond Limited, providing flexibility and potential for value appreciation based on the real estate business’s performance.

Conclusion

Raymond’s demerger of its real estate arm is a landmark step in the group’s ongoing transformation. By granting shareholders a direct stake in Raymond Realty, the company is unlocking value and setting the stage for focused growth in both its core businesses. As Raymond Realty prepares for its debut on the stock exchanges, investors and market watchers alike will be keenly observing its next moves in India’s dynamic real estate sector.

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Fenesta Invests in DNV Global to Strengthen Industry Hold

 Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

 Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

Dr. Reddy’s Laboratories Stock Slides Amid High Trading Volumes

 

Amid increased investor activity and market uncertainty, Dr. Reddy’s faces pressure as its shares trend downward despite sound fundamentals.

Introduction

In early May 2025, Dr. Reddy’s Laboratories, one of India’s leading pharmaceutical firms, saw its share price retreat notably during high-volume trading sessions. The stock registered multiple days of decline, slipping close to ₹1,156 by May 6. Despite consistent earnings and a stable operational outlook, investors appear to be reacting to broader market forces and sectoral headwinds.
The sudden rise in trading activity alongside price depreciation has raised questions: Is this a short-term market overreaction, or a signal of deeper challenges?

Stock Performance Overview

Over the past week, Dr. Reddy’s stock has consistently traded in the red, marking a fall of nearly 2% in just one day, followed by successive dips. By May 6, the share was down 1.28%, closing at ₹1,156.50.
Interestingly, this drop coincided with unusually high trading volumes — a telltale sign of strong institutional or speculative activity. Such a pattern often suggests heightened investor sentiment, though not always driven by fundamental changes.

Technical Indicators Show Weak Momentum

Analysts have noted that Dr. Reddy’s shares are currently trading below several key moving averages — including the 5-day, 20-day, 50-day, 100-day, and 200-day marks. This trend typically indicates a bearish outlook in the short term and can prompt algorithmic and institutional traders to offload holdings, thereby accelerating the decline.
The company’s stock also appears to be underperforming the broader pharmaceutical index, a sector that itself is facing renewed pressure due to regulatory concerns, pricing fluctuations, and global competition.

Company Fundamentals Remain Strong

Despite the downward movement in share price, Dr. Reddy’s core financials remain healthy. The company has demonstrated consistent revenue growth over recent quarters, with a solid balance sheet and a competitive pipeline of generics and specialty drugs.
Its price-to-earnings (P/E) ratio, currently around 18.02, is significantly lower than the industry average, suggesting the stock may be undervalued relative to peers. This makes the recent downturn even more puzzling when viewed through the lens of strong business fundamentals.

Sectoral and Market Sentiment at Play

The broader pharmaceutical sector has been facing uncertainty, especially with increasing scrutiny on drug pricing, both domestically and in export markets like the US. In addition, currency fluctuations and raw material cost pressures have contributed to volatility.
Investors may also be taking a cautious stance amid upcoming regulatory updates or waiting on quarterly earnings from peer companies before recalibrating positions. Furthermore, large-cap pharma stocks like Dr. Reddy’s often serve as barometers for institutional investors who adjust allocations based on broader risk appetite.

Analyst and Investor Perspectives

While some analysts see this as a routine market correction, others suggest it could be a signal of shifting investor focus from defensives like pharmaceuticals to other emerging sectors, such as banking or capital goods, especially as interest rate expectations change.
There’s also speculation that part of the sell-off may be due to portfolio rebalancing by large funds at the start of the new fiscal quarter.
Nonetheless, retail investors are advised to remain cautious. For long-term holders, the current dip may offer an opportunity to accumulate at more attractive valuations, provided the fundamentals remain intact.

Conclusion

Dr. Reddy’s Laboratories is no stranger to market fluctuations, but the recent slide in its share price—despite no apparent deterioration in financial performance—highlights the complex interplay between technical, investor psychology, and sector-wide sentiment.
While the stock’s current trajectory may concern short-term traders, long-term investors might view this as a healthy correction or even a buying opportunity. As always, close monitoring of future earnings, regulatory updates, and global pharma trends will be crucial in determining the path ahead.

 

 

 

 

The image added is for representation purposes only

Disney Set to Absorb $300 Million Loss After India JV Overhaul with Reliance

Investor Frenzy: Chemkart, Smarten IPOs 5x Oversubscribed!

SME IPO Migration: Key Changes in SEBI Guidelines

SME IPO Migration: Key Changes in SEBI Guidelines

On 18th December 2024, the Securities and Exchange Board of India (SEBI) issued revised guidelines for Small and Medium Enterprises (SMEs) seeking to migrate from the SME platform to the mainboard of stock exchanges. These updated norms aim to ensure financial robustness and operational stability for companies making the transition. The guidelines apply to both BSE and NSE platforms and are as follows:

Migration to Mainboard
For SMEs to migrate to the BSE Mainboard, they must meet the following criteria:

  • Paid-up Capital: The company should have a paid-up capital exceeding ₹10 crores.
  • Market Capitalization: The company’s market capitalization must be at least ₹25 crores.
  • Net Worth: A minimum net worth of ₹15 crores for the two preceding full financial years is required.
  • Listing Duration: The company must have been listed on the SME platform of the Exchange for at least three years.
  • Positive EBITDA: The company should have posted a positive EBITDA for at least two out of the last three financial years.
  • Positive PAT: A positive Profit After Tax (PAT) in the immediate financial year of making the migration application is necessary.
    Migration to NSE Mainboard

For SMEs to migrate to the NSE Mainboard, the guidelines are slightly stricter, requiring:

  • Paid-up Capital: The company must have a paid-up capital of ₹10 crores or more.
  • Market Capitalization: A minimum market capitalization of ₹25 crores is mandatory.
  • Net Worth: The company should have a net worth of at least ₹75 crores.
  • Listing Duration: A listing period of three years on the SME platform is essential.
  • Positive EBITDA: A positive EBITDA from operations for each of the preceding three financial years is required.
  • Positive PAT: The company must show a positive PAT in the immediate financial year prior to applying for migration.

Disclaimer
These guidelines, issued on 18th December 2024, are subject to change at the discretion of the exchanges.

The revised criteria reinforce the importance of consistent financial performance and operational maturity for SMEs looking to scale up to the mainboard.

The image added is for representation purposes only

TCS Unveils Pace Studio in Philippines to Boost Digital Innovation

Equity Right

Government allows Indian public companies to directly list shares overseas.

Government allows Indian public companies to directly list shares overseas.

 

Government’s vision for betterment of Indian companies:

In late January 2020 Government of India communicated to media that they are planning to allow direct listing of Indian companies in foreign markets. This will help Indian companies to not only rely on domestic markets but they can also raise capital on large scale from various foreign markets which will help companies in diversification and growth. This move can directly help Indian companies in increasing their turnover and profits.

Till now Indian companies go for the depository receipts to attract investors globally but this is bit unfamiliar amongst the investors globally and been less attractive in recent years. A minimum of 15 Indian companies currently attract foreign investors via ADR’s and GDR’s. These companies includes Reliance Industry, HDFC Bank, Infosys and many others.

 

Green signal by Indian Government:

Finance Minister Nirmala Sitharaman had announced an economic package of ₹ 20 lakh crore under government’s Atma Nirbhar Bharat Abhiyan. This is done for the revival of Indian Economy. It is an umbrella of massive ₹ 20 lakh crore economic booster package. The government ensured to provide some relaxation in all the sectors.

To improve “ease of doing business” in India, government allowed Indian public companies to list their shares in foreign markets. This provision will help Indian companies for better valuations, rapid growth and expand their businesses on a large scale. This move will help Indian companies to get funds at a cheaper rate from various foreign markets. This will directly help Indian economy to recuperate in a speedy way.

Government noted private companies that listed Non-convertible debentures (NCDs) on Indian stock exchanges not to be considered as listed companies. It is also expected that this provision is to prevent Indian companies to register themselves in foreign markets like Singapore and London for raising a fund and going global.

 

Existing vs proposed rule:

The existing rule states that companies which are listed on Indian stock markets can only list their company in foreign markets. Whereas, new proposed rule states that there is no compulsion for it. Indian companies can list themselves directly in various foreign markets to raise capital.

Until now, only American Depository Receipt (ADR’s) and Global Depository Receipt (GDR’s) can collect capital from foreign market sources. At least 15 Indian companies follow this mechanism to raise capital from foreign markets. However, this is not much familiar amongst the global investors. To eradicate this the new provision will allow Indian companies to a fresh new issue of shares or sale of existing holdings.

 

Rules and regulation:

All the required rules and regulation for listing an Indian company at abroad will be notified soon by the government. Once the provisions to the Foreign Exchange Management Act (FEMA) and Company Law Regulations are passed. Media noted Indian foreign exchange control laws do not require free capital convertibility, and there are other regulatory limits on capital account transactions.

Nevertheless, this proposal has been under discussion for a couple of years between stakeholders and regulators, especially regarding the selection of foreign jurisdiction. SEBI had indicated in 2018 that this route would be open only to the financially sound companies, so that the mechanism could not be used for exploitation. Sources indicated that final rules in this respect would probably be based on the Financial Action Task Force’s recommendations.

Finance Minister Nirmala Sitharaman noted, this provision of direct listing. If Indian public companies are not available over the globe but will be allowed in permissible jurisdictions.

 

Precautionary measures:

However, the approval will not come without any protections. The Indian government is likely to go along with the recommendations raised by SEBI in 2018. This requires a direct listing of Indian companies in abroad. It had suggested 10 overseas jurisdictions, including the US, UK, Japan, China, Hong Kong and South Korea for Indian companies to list. The selection was based on the fact that these jurisdictions are part of the Financial Action Task Force (FATF), The Anti-Money Laundering Global Task Force (GTF-AML) and IOSCO.

SEBI also suggested that this provision should be available only for financially stable . This will aid  to minimize frauds and manipulation. The firms with a  paid-up capital of 10% will be allowed to list in the foreign market.

The provision of capital raising in an overseas market can also have an impact on the Indian currency market. Since the flow of overseas capital can put pressure on the Indian currency and may lead to volatility. RBI and SEBI can be jointly involved to check this.

 

 

 

Equity Rght

BSE, NSE cut listing fees for SMEs

BSE, NSE cut listing fees for SMEs

 

Due to COVID-19 pandemic, all the sectors have been affected badly but SMEs segments are affected the most. Therefore, during the announcements of details of Rs 20 lakh crore stimulus package, Finance minister Nirmala Sitharaman made special announcements related to MSMEs.

 

Reduction in listing fees:

Now to support SMEs and MSMEs, Indian stock exchanges BSE and NSE came forward. They have relaxed listing norms and reduced listing fee for small and medium enterprises by 25%. However, this norms are applicable to both existing and new firms which are looking forward to list on BSE SME platform and NSE SME platform.

 

What are the Current charges?

Currently for SMEs, Rs 25,000 or 0.1 percent of market capitalization of firm is the listing fee charged by BSE. The NSE charges around Rs 10,000 to Rs 45,000, depending on the SME firms market capitalization. Until now, BSE has 322 small and medium companies listed and has raised around Rs 3,278.84 crore from the market. Their market capitalisation is of Rs 15,865.39 crore so far. On the other side, so far only 209 small and medium companies are listed on NSE and have raised over Rs 3,200 crore.

 

What measures have been announced by government?

Due to the covid-19 lock down, many industries are facing problems like job losses and are cash strapped. During this situation, the main concern for MSMEs is that they are not able to restart their operations due to supply issues and non-availability of labour. Last week, while making announcement for packages in tranches, government changed the definition for MSMEs and linked it to the turnover limits of the companies so that their businesses grow with benefits. They announced measures for MSMEs and Rs 3 lakh crore package for collateral free automatic loans with separate funds for equity support.

However, these Rs 3 lakh crore will also be useful for existing borrowers who have over Rs 100 crore turnover and Rs 25 crore outstanding. Fresh loans can be taken by companies up to 20% of their outstanding. These loans have tenure of 4 years, with moratorium repayment period of 12 months. However, the government will also give them credit guarantee of 100 percent which will cover interest and principal to banking and non-banking institutions. Government will give around Rs 4,000 crore funds to Credit Guarantee Fund Trust for Micro and Small Enterprises (CGFTMSE) with partial credit guarantee to banks. However for expansion of MSMEs, the government will provide corpus of Rs 10,000 crore so that they can also list after expansion.

 

Further Expectations:

Micro, small and medium enterprises (MSMEs) are very cautious while taking any kind of fresh loans, as they are not sure about the demands for their products after all activity resumes. Most of the micro, small and medium businesses and enterprises are expecting from the government, to give them direct relief by waiving their electricity bills and other fixed expenditure such as payment of salaries. However, banks have already reduced their loans such as credit limit. Anil Bhardwaj, Secretary general of federation of Indian micro, small & medium enterprises (FISME) said, for all the small business and enterprises, government will take care of their fixed expenses. MSME industry has three major demand, interest payments, easy access to loans and payments of salaries from the government, during this situation due to COVID-19 lock down.

 

 

FPIs exit markets after economic package announcement.

Z47 Launches $400M Fund for India's Tech Boom

BSE, NSE to launch rupee derivative contracts

BSE, NSE to launch rupee derivative contracts

 

The NSC IFSC  and India INX have introduced rupee derivatives which will help in bringing much needed added liquidity in the economy. This will supplement their customers with several investment options.

The motive behind introduction of rupee derivatives:

The CEO of NSE, Vikram Limaye communicated to the media that the introduction of rupee derivatives will help in the development of (Gujarat International finance tech) GIFT IFSC as a hub of global financial services. This IFSC platform will help in the rupee exposure of non resident participants. This non residents’ participation will also enhance the IFSC’s extended trading hours and USD settlement. They’ve already received permissions for offering securities trading in any currency except the Indian rupee.

 

Importance of introduction of rupee derivatives:

Mr. Limaye added that this measure will enhance the efficiency of Indian rupees’ price discovery. It will be done by eliminating the onshore and offshore markets’ segmentation. It will also allow for trading and hedging using rupee derivatives contracts to their trading partners viz. IFSC entities and banking units. The Finance Minister Nirmala Sitharaman did the inauguration of the rupee derivatives contract. The contract will be having a lot size in NSE IFSC – Rs 20 lacs and India INX – Rs 10 lacs and the contract will be settled in cash.

 

The futures and options:

The futures at the NSE IFSC will have in total three monthly expiry contracts . The options at NSE IFSC will have total seven weekly and three monthly expiry contracts. For the other one i.e India INX, there will be in total eleven weekly and twelve monthly contracts. In the past few months due to the corona virus pandemic crisis, there is an acute volatility faced by the currency markets. The introduction of rupee derivative contracts in the IFSC will lead to more stability during these situations.

 

The Contracts:

The chairman of India INX, Ashishkumar Chauhan communicated to the media that the size of contract will be Rs 10 lacs and the trading is made available from 8th May 2020, 3:30 pm IST. The trading is for both the pairs viz. USD-INR and INR-USD. He added that for the USD-INR product, many of the people like the exporters, importers, traders, etc associated with any kinds of businesses have expressed their keen interest. The Gandhinagar GIFT City is the only IFSC situated in India having zero short term, zero long-term, zero stamp duty and zero transaction taxes as of now.

Each and every businessman interested should consider trading and hedging using rupee derivatives contracts at the GIFT City. The MD and CEO of India INX, V Balasubramaniam communicated to the media that he looks towards the best participation of members and international participants. This will be the first launch of offshore Indian rupee derivatives contract.

 

 

What are liquid funds? Find more